首页> 美国卫生研究院文献>other >Novel Method to Load Multiple Genes onto a Mammalian Artificial Chromosome
【2h】

Novel Method to Load Multiple Genes onto a Mammalian Artificial Chromosome

机译:将多个基因加载到哺乳动物人工染色体上的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mammalian artificial chromosomes are natural chromosome-based vectors that may carry a vast amount of genetic material in terms of both size and number. They are reasonably stable and segregate well in both mitosis and meiosis. A platform artificial chromosome expression system (ACEs) was earlier described with multiple loading sites for a modified lambda-integrase enzyme. It has been shown that this ACEs is suitable for high-level industrial protein production and the treatment of a mouse model for a devastating human disorder, Krabbe’s disease. ACEs-treated mutant mice carrying a therapeutic gene lived more than four times longer than untreated counterparts. This novel gene therapy method is called combined mammalian artificial chromosome-stem cell therapy. At present, this method suffers from the limitation that a new selection marker gene should be present for each therapeutic gene loaded onto the ACEs. Complex diseases require the cooperative action of several genes for treatment, but only a limited number of selection marker genes are available and there is also a risk of serious side-effects caused by the unwanted expression of these marker genes in mammalian cells, organs and organisms. We describe here a novel method to load multiple genes onto the ACEs by using only two selectable marker genes. These markers may be removed from the ACEs before therapeutic application. This novel technology could revolutionize gene therapeutic applications targeting the treatment of complex disorders and cancers. It could also speed up cell therapy by allowing researchers to engineer a chromosome with a predetermined set of genetic factors to differentiate adult stem cells, embryonic stem cells and induced pluripotent stem (iPS) cells into cell types of therapeutic value. It is also a suitable tool for the investigation of complex biochemical pathways in basic science by producing an ACEs with several genes from a signal transduction pathway of interest.
机译:哺乳动物人工染色体是基于天然染色体的载体,就大小和数量而言,它们可能携带大量遗传物质。它们相当稳定,在有丝分裂和减数分裂中均能很好地隔离。平台人工染色体表达系统(ACEs)较早时已描述,具有修饰的Lambda整合酶的多个加载位点。事实证明,这种ACEs适用于高水平的工业蛋白质生产,并适合治疗具有破坏性的人类疾病(克拉伯氏病)的小鼠模型。 ACEs处理的携带治疗基因的突变小鼠的寿命是未治疗小鼠的四倍以上。这种新的基因疗法被称为哺乳动物人工染色体-干细胞疗法。目前,该方法的局限性在于,对于加载到ACEs上的每个治疗基因,都应存在一个新的选择标记基因。复杂的疾病需要几种基因的协同作用才能进行治疗,但是只有有限数量的选择标记基因可用,而且由于这些标记基因在哺乳动物细胞,器官和生物体中的有害表达而造成严重副作用的风险。我们在这里描述了一种仅使用两个可选标记基因将多个基因加载到ACE上的新颖方法。这些标记物可在治疗应用前从ACEs上清除。这项新技术可以彻底改变针对复杂疾病和癌症的基因治疗应用。通过允许研究人员设计具有预定遗传因子集的染色体,从而将成体干细胞,胚胎干细胞和诱导性多能干(iPS)细胞分化为具有治疗价值的细胞类型,它还可以加快细胞治疗。通过从目标信号转导途径中产生带有多个基因的ACE,它也是研究基础科学中复杂生化途径的合适工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号